Compare Becton Dickinson and Co (BDX) vs Opendoor Technologies Inc (OPEN) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Becton Dickinson and Co vs Opendoor Technologies Inc — how do they compare? Becton Dickinson and Co trades at $156.47 (market cap $41.51B), while Opendoor Technologies Inc trades at $4.79 (market cap $4.39B). The key difference: Becton Dickinson and Co is far larger — about 9.5× Opendoor Technologies Inc's market cap, and Becton Dickinson and Co pays a 2.79% dividend while Opendoor Technologies Inc pays none. Which is the better fit depends on your goals.
| BDX | OPEN | |
|---|---|---|
Market Cap | $41.51B | $4.39B |
Sector | Health | Real Estate |
52-Week High | $185.39 | $10.52 |
52-Week Low | $135.49 | $1.04 |
Enterprise Value | $57.97B | $4.73B |
Dividend Yield | 2.79% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
BDX trades at $153.83, up 1.24% today, with technical indicators showing a neutral to bullish bias. The company has consistently beaten earnings estimates in recent quarters, with Q1 2026 EPS of $2.90 exceeding expectations. Revenue growth remains steady, reaching $21.84B in 2025, though net margins have compressed to 5.12%. Recent news highlights BDX's innovation in medical technology and positive analyst sentiment.
The outlook for BDX appears balanced. Upside potential exists from continued earnings beats and strategic positioning in growing healthcare segments like GLP-1 drug support equipment. However, risks include margin pressure, elevated debt levels, and cautious hospital spending. The consensus price target of $173.40 suggests moderate upside from current levels.
Opendoor (OPEN) trades at $4.485, down 5.86% today, reflecting ongoing volatility amid a challenging housing market. The stock shows a bearish technical trend with support near $4 and resistance at $5. Fundamentally, the company reported a net loss of $1.30 billion on $4.37 billion revenue in 2025, with a negative net margin of 35.25%. Recent news highlights CEO leadership and a shift toward AI, including the closure of India operations affecting 250 employees (Reuters, 2026-06-11).
The outlook remains cautious due to persistent losses and high debt, though the low P/S ratio of 0.94 offers some valuation appeal. Risks include execution of the new business model, interest rate sensitivity, and competitive pressure. Analyst sentiment is mixed with 65.39% hold ratings, indicating wait-and-see approach until sustained profitability emerges.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Becton Dickinson and Co
Becton, Dickinson is the world's largest manufacturer and distributor of medical surgical products, such as needles, syringes, and sharps-disposal units. The company also manufactures diagnostic instruments and reagents, as well as flow cytometry and cell-imaging systems. BD Interventional (largely the former Bard business) accounts for 23% of revenue. International revenue accounts for 44% of the company's business.
Read more on BDX →About Opendoor Technologies Inc
Opendoor Technologies Inc is a digital platform for residential real estate. This platform enables customers to buy and sell houses online. It generates revenue through home sales, along with other revenue from real estate services.
Read more on OPEN →
